Skip to main content
Stock Info
NASDAQSY

Prof. Chao He

Independent Director

Prof. Chao He has served as our independent director since May 2020. Prof. He is currently a professor of surgical oncology in the Medical School of Zhejiang University and has over 20 years of clinical practice experience. Prof. He has also served as the independent director of Baida Group Co., Ltd. (Shanghai Stock Exchange: 600865) since May 2020 and the independent director of Lionco Pharmaceutical Group Co., Ltd. (Shanghai Stock Exchange: 603669) since February 2019. Prof. He  has served as the director and general manager of Greentown Medical Management Company since 2021. He served as a senior vice president in WeDoctor Group and the chief executive officer of WeDoctor Primary Care from 2016 to 2019. Prior to that, he was the vice general manager in healthcare affairs at Taikang Community Investment Co., Ltd. from 2014 to 2016. Prof. He practiced as a physician and also took on managerial roles in Sir Run Run Shaw Hospital, a hospital affiliated with the Medical School of Zhejiang University, in Hangzhou, Zhejiang from 1999 to 2014. He was the president of Sir Run Shaw Hospital from 2003 to 2013. He practiced in the First Affiliated Hospital of Zhejiang University from 1983 to 1999, where he also served as a vice president from 1993 to 1999. Prof. He received his bachelor’s degree in medicine from Zhejiang Medical University in 1982, where he also obtained his master’s degree in medicine in 1989. He received an EMBA degree from CEIBS International Business School in 2003.